Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PURIXAN | Nova Laboratories | N-205919 RX | 2014-04-28 | 1 products, RLD, RS |
PURINETHOL | Stason Pharmaceuticals | N-009053 RX | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
mercaptopurine | ANDA | 2025-02-21 |
purixan | New Drug Application | 2024-10-25 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
non-hodgkin lymphoma | — | D008228 | C85.9 |
precursor cell lymphoblastic leukemia-lymphoma | — | D054198 | C91.0 |
b-cell chronic lymphocytic leukemia | — | D015451 | C91.1 |
Code | Description |
---|---|
S0108 | Mercaptopurine, oral, 50 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Mercaptopurine |
INN | mercaptopurine |
Description | Purine-6-thiol is a thiol that is the tautomer of mercaptopurine. It has a role as an antineoplastic agent and an antimetabolite. It is a tautomer of a mercaptopurine. It derives from a hydride of a 7H-purine. |
Classification | Small molecule |
Drug class | aptamers, classical and mirror |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O.S=c1[nH]cnc2nc[nH]c12 |
PDB | — |
CAS-ID | 6112-76-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1200751 |
ChEBI ID | 31822 |
PubChem CID | 667490 |
DrugBank | DB01033 |
UNII ID | PKK6MUZ20G (ChemIDplus, GSRS) |